These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27118574)

  • 1. Combinational strategies of metformin and chemotherapy in cancers.
    Zhang HH; Guo XL
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):13-26. PubMed ID: 27118574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
    Chen G; Xu S; Renko K; Derwahl M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E510-20. PubMed ID: 22278418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.
    Hirsch HA; Iliopoulos D; Tsichlis PN; Struhl K
    Cancer Res; 2009 Oct; 69(19):7507-11. PubMed ID: 19752085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. At the crossroads of cancer stem cells and targeted therapy resistance.
    Wang A; Qu L; Wang L
    Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin in breast cancer: preclinical and clinical evidence.
    De A; Kuppusamy G
    Curr Probl Cancer; 2020 Feb; 44(1):100488. PubMed ID: 31235186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
    Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
    Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of chemotherapy and cancer stem cell targeting agents: Preclinical and clinical studies.
    Li Y; Atkinson K; Zhang T
    Cancer Lett; 2017 Jun; 396():103-109. PubMed ID: 28300634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and prostate cancer stem cells: a novel therapeutic target.
    Mayer MJ; Klotz LH; Venkateswaran V
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):303-9. PubMed ID: 26215782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
    Yang Q; Zhang T; Wang C; Jiao J; Li J; Deng Y
    Eur J Pharm Biopharm; 2014 Nov; 88(3):737-45. PubMed ID: 25460146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in lung cancer: rationale for a combination therapy.
    Morgillo F; Sasso FC; Della Corte CM; Festino L; Manzo A; Martinelli E; Troiani T; Capuano A; Ciardiello F
    Expert Opin Investig Drugs; 2013 Nov; 22(11):1401-9. PubMed ID: 23937224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types.
    Iliopoulos D; Hirsch HA; Struhl K
    Cancer Res; 2011 May; 71(9):3196-201. PubMed ID: 21415163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?
    Shah RR
    Drug Saf; 2017 Mar; 40(3):211-228. PubMed ID: 27981444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of metformin with chemotherapeutic drugs via different molecular mechanisms.
    Peng M; Darko KO; Tao T; Huang Y; Su Q; He C; Yin T; Liu Z; Yang X
    Cancer Treat Rev; 2017 Mar; 54():24-33. PubMed ID: 28161619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between anticancer effect of metformin and the transcriptional regulation of certain genes (CHOP, CAV-1, HO-1, SGK-1 and Par-4) on MCF-7 cell line.
    Salis O; Bedir A; Ozdemir T; Okuyucu A; Alacam H
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1602-9. PubMed ID: 24943970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review.
    Ahmed ZSO; Golovoy M; Abdullah Y; Ahmed RSI; Dou QP
    Recent Pat Anticancer Drug Discov; 2021; 16(2):161-186. PubMed ID: 34132186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic anti-proliferative effect of metformin and sorafenib on growth of anaplastic thyroid cancer cells and their stem cells.
    Chen G; Nicula D; Renko K; Derwahl M
    Oncol Rep; 2015 Apr; 33(4):1994-2000. PubMed ID: 25683253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
    Ikhlas S; Ahmad M
    Life Sci; 2017 Sep; 185():53-62. PubMed ID: 28755883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and Angiogenesis in Cancer - Revisited.
    Kannarkatt J; Alkharabsheh O; Tokala H; Dimitrov NV
    Oncology; 2016; 91(4):179-184. PubMed ID: 27487294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin alters therapeutic effects in the BALB/c tumor therapy model.
    Meyer FB; Goebel S; Spangel SB; Leovsky C; Hoelzer D; Thierbach R
    BMC Cancer; 2021 May; 21(1):629. PubMed ID: 34044797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.